Belite Bio (BLTE) Q1 2026 Earnings Transcript
Source: Motley Fool
2026-05-20 17:59:46 ET
Image source: The Motley Fool.
Wednesday, May 20, 2026 at 4:30 p.m. ET
Need a quote from a Motley Fool analyst? Email pr@fool.com
Belite Bio Inc
NASDAQ: BLTE
BLTE Trading
2.87% G/L:
$153.635 Last:
198,464 Volume:
$150.63 Open:
BLTE Latest News
July 06, 2026 08:00:00 am
Belite Bio to Participate in the Piper Sandler Virtual Ophthalmology Investor Symposium
July 06, 2026 07:00:00 am
Belite Bio Announces Oral Presentations at Two Upcoming Medical Conferences
June 12, 2026 09:30:00 pm
Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1
June 02, 2026 08:00:00 am
Belite Bio to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
$6,636,713,193
14,510,659
N/A
18
N/A
Biotechnology & Life Sciences
Healthcare
US
San Diego
